Bearish
Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS
The Rosen Law Firm has announced an investigation into potential securities claims against Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), all...